On February 7, shares of Glenmark Pharmaceuticals Ltd ended at ₹1,543.35, up by ₹45.15, or 3.01% on the BSE. Previous Post Cipla unit gets a Voluntary Action Indicated status from the USFDA Next Post Vedanta faces ₹141.36 crore GST demand over Input Tax Credit issues, plans to appeal Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
